GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Balchem Corp (NAS:BCPC) » Definitions » Capex-to-Revenue

Balchem (Balchem) Capex-to-Revenue : 0.05 (As of Dec. 2023)


View and export this data going back to 1986. Start your Free Trial

What is Balchem Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Balchem's Capital Expenditure for the three months ended in Dec. 2023 was $-11.58 Mil. Its Revenue for the three months ended in Dec. 2023 was $228.70 Mil.

Hence, Balchem's Capex-to-Revenue for the three months ended in Dec. 2023 was 0.05.


Balchem Capex-to-Revenue Historical Data

The historical data trend for Balchem's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Balchem Capex-to-Revenue Chart

Balchem Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.05 0.05 0.05 0.04

Balchem Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.04 0.04 0.04 0.05

Competitive Comparison of Balchem's Capex-to-Revenue

For the Specialty Chemicals subindustry, Balchem's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Balchem's Capex-to-Revenue Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Balchem's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Balchem's Capex-to-Revenue falls into.



Balchem Capex-to-Revenue Calculation

Balchem's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-37.892) / 922.439
=0.04

Balchem's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-11.575) / 228.699
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Balchem  (NAS:BCPC) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Balchem Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Balchem's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Balchem (Balchem) Business Description

Traded in Other Exchanges
Address
5 Paragon Drive, Montvale, NJ, USA, 07645
Balchem Corp is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, agricultural, and medical sterilization industries. The segments include 1) Human Nutrition and Health segment provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. 2) Animal Nutrition and Health segment provide nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride. 3) Specialty Products segment includes re-packaging and distributing a number of performance gases and chemicals for various uses, notably ethylene oxide, propylene oxide, and ammonia.
Executives
David B Fischer director 425 WINTER ROAD, DELAWARE OH 43015
Olivier Rigaud director CORBION NV, PIET HEINKADE 127, AMSTERDAM P7 1019 GM
Monica Vicente director C/O FRESH DEL MONTE PRODUCE INC., P.O. BOX 149222, CORAL GABLES FL 33114
Michael Robert Sestrick officer: Chief Technology Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Frederic Boned officer: SVP/GM, Human Nutri. & Health 5 PARAGON DRIVE, MONTVALE NJ 07645
Van Gunsteren Job Leonard officer: Vice President 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Hatsuki Miyata officer: General Counsel and Secretary 5 PARAGON DRIVE, MONTVALE NJ 07645
Michael Bent Tignor officer: Chief Human Resources Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Jonathan Harrison Griffin officer: Vice President 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Martin Luther Reid officer: Chief Supply Chain Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
William A. Backus officer: Chief Accounting Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Kathleen B Fish director ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
James C Hyde officer: Sr. Vice President 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Scott C Mason officer: Vice President C/O NOVAMERICAN STEEL INC, 1050 UNIVERSITY AVENUE, NORWOOD MA 02062
Joyce J. Lee director C/O ZOETIS INC., 100 CAMPUS DRIVE, FLORHAM PARK NJ 07940